Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0.360. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →European Commission
Grant: 875510
EUbOPEN: Enabling and Unlocking biology in the OPEN
European Commission
Grant: 821600
Saracatinib Trial tO Prevent FOP
Wellcome Trust
Grant: 106169
A UK Hub to Catalyse Open Target Discovery.
National Institutes of Health
Grant: 3R01AR057374-07S1
Novel probes of BMP and TGF-beta signaling and function
Fields of Study
Keywords
Sustainable Development Goals